Risk factors for end-stage renal disease: 25-year follow-up
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationObesity-Related Chronic Kidney Disease-The Role of Lipid MetabolismContextual poverty, nutrition, and chronic kidney diseasePesticide exposure and end-stage renal disease risk among wives of pesticide applicators in the Agricultural Health StudyUric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese populationPesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health StudyHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationEndemic Nephropathy Around the WorldSocial Determinants of Racial Disparities in CKD.Geographic variation in black-white differences in end-of-life care for patients with ESRD.Predictors of end-stage renal disease in the urban poor.Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.Obesity in elderly subjects: in sheep's clothing perhaps, but still a wolf!Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease.Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar NephrosclerosisDyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.Diabetes care in black and white veterans in the southeastern U.S.A genome-wide association study of serum uric acid in African Americans.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-upPredicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study.Uric acid: a novel mediator and marker of risk in chronic kidney disease?New role for plasmin in sodium homeostasis.Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)Comorbidities in patients with crystal diseases and hyperuricemia.Risk factors for progression of chronic kidney disease.Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort.Urolithiasis and the risk of ESRD.The relationship between serum uric acid and chronic kidney disease among Appalachian adultsThe serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention TrialSwitching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney diseasePrediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyIncidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort.Familial risks of kidney failure in Sweden: a nationwide family studyAdiponectin effects on the kidney.Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.Homelessness and risk of end-stage renal diseaseSerum uric acid and chronic kidney disease: the role of hypertension.
P2860
Q22306356-2D538327-1B44-4134-BCD7-D9F53B124980Q26774143-6268345B-DEE4-41BD-AB4C-E1A6527A97FFQ27025550-053051D6-7B1C-4CCE-ABE8-364BAAABD233Q28394940-331D62E8-AB23-40C4-AE39-3BF35464BB28Q28547672-937DB638-AD10-498B-B399-31D39C6E1C72Q29248563-B3930903-3F5B-4E14-9F2C-F11D95089BDCQ29547236-DA00126C-4DFC-4860-AA96-DDDDD8EB2A24Q29547691-F9CE1354-9D0F-4983-8F1B-594B4ED831B4Q29547909-609854A6-67A9-4C35-B136-7750FB2F88FDQ30234991-A0EBEFAB-B0E4-4C15-B586-C2E234B0C44FQ30250319-BD803FB7-3A35-4A67-9C01-5301BC293642Q30541137-577956DB-401B-4893-A840-4A4A606C054DQ30657896-BF35CEB1-CF90-420F-A2F6-A1F0BA173198Q33358818-445538B0-E97D-42D6-83E0-732583C6125AQ33610732-0E7C50D7-C915-414A-AFFB-E7347E6467B4Q33611859-70581C3C-E252-478E-8D58-174568674DA6Q33715840-D9194BAF-5093-4791-BFB4-8D70AA95A11CQ33752285-285CB720-4242-4E24-95BF-8BAD9FC0FA70Q33776176-7C84AEE6-AF45-4A34-8A39-2191470CE0E8Q33804752-1FF556DC-F6BD-441B-A099-E54D3C5125CAQ33812108-3FC05CA7-40E6-465B-8B9B-B15A3CD0BB9BQ33873169-B52D0F6F-5C18-48C5-BD54-BC548A2A0D70Q33890631-EE94C870-F7CB-4BAE-BB4D-2CC6626FDC3EQ33913892-46FBD4AE-6570-4514-B4DE-DD589764631AQ33950593-A564216B-04E1-404E-B72F-E3CECCDA2C88Q33983415-EB5A1C5D-AC0E-4FA8-AC10-43B2F632081EQ34157725-123B0742-662A-4EAC-BF26-9D8BCD5892ADQ34169794-75788827-DFFC-4F6C-8E7E-5FD3159F3B85Q34181148-E446F344-8CE2-4137-A4B3-93ACCF602F55Q34284900-4C26E197-2A36-4E88-AF59-05A7D506BD53Q34308220-E64F0DED-ACC5-4B80-9065-EA7EA89CC25DQ34310754-CE11F5CF-8578-4F9B-B976-50C44AF032A1Q34317722-47ABE44E-1495-46EE-B306-2D268A8A2C6DQ34349235-714B3EA3-DDAF-4E43-BF16-30C6E2DA6D45Q34428670-7AE23793-67E5-4461-BC76-DAC4F180BDDBQ34572057-6DDB3AE5-0688-4506-BF2E-C6ABE25C12E1Q34614727-E3A2C119-93AC-468E-BE3F-CBF2FD7031FAQ34658933-E19D8922-4B63-4343-A118-F9798EB3854BQ34841427-ECAF9278-784F-45F0-AE45-DE5BB2766693Q35050256-8602B58B-EF0D-4A1A-85C4-1D89D09BB135
P2860
Risk factors for end-stage renal disease: 25-year follow-up
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk factors for end-stage renal disease: 25-year follow-up
@en
Risk factors for end-stage renal disease: 25-year follow-up.
@nl
type
label
Risk factors for end-stage renal disease: 25-year follow-up
@en
Risk factors for end-stage renal disease: 25-year follow-up.
@nl
prefLabel
Risk factors for end-stage renal disease: 25-year follow-up
@en
Risk factors for end-stage renal disease: 25-year follow-up.
@nl
P2093
P2860
P1476
Risk factors for end-stage renal disease: 25-year follow-up
@en
P2093
Carlos Iribarren
Charles E McCulloch
Chi-yuan Hsu
Jeanne Darbinian
P2860
P304
P356
10.1001/ARCHINTERNMED.2008.605
P407
P577
2009-02-01T00:00:00Z